A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

A simplified system for generating recombinant adenoviruses

He, T., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,209 · see citing works

Induction of apoptosis in fibroblasts by c-myc protein

Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941 · see citing works

Creation of human tumour cells with defined genetic elements

Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · see citing works

Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint

Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,379 · see citing works

MYC oncogenes and human neoplastic disease

Nesbit, C. E., Tersak, J. M., & Prochownik, E. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202746 · Cited by 1,163 · see citing works

Teratocarcinomas and Embryonic Stem Cells: A Practical Approach

Robertson, E. J., & Beddington, R. (1988) · Development · doi:10.1242/dev.102.1.3 · Cited by 1,034 · see citing works

Teratocarcinomas and embryonic stem cells: A practical approach

Krumlauf, R. K. (1987) · Trends in Genetics · doi:10.1016/0168-9525(87)90286-1 · Cited by 782 · see citing works

THE myc ONCOGENE: ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION

Cole, M. D. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.002045 · Cited by 695 · see citing works

Function of WW Domains as Phosphoserine- or Phosphothreonine-Binding Modules

Lu, P., Zhou, X. Z., Shen, M., & Lu, K. P. (1999) · Science · doi:10.1126/science.283.5406.1325 · Cited by 683 · see citing works

Control of c-myc Regulation in Normal and Neoplastic Cells

Spencer, C. A., & Groudine, M. T. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)60476-5 · Cited by 612 · see citing works

Enumeration of the Simian Virus 40 Early Region Elements Necessary for Human Cell Transformation

Hahn, W. C., Dessain, S. K., Brooks, M. W., King, J. E., Elenbaas, B., Sabatini, D. M., DeCaprio, J. A., & Weinberg, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2111-2123.2002 · Cited by 603 · see citing works

Pin1-Dependent Prolyl Isomerization Regulates Dephosphorylation of Cdc25C and Tau Proteins

Zhou, X. Z., Kops, O., Werner, A., Lu, P., Shen, M., Stoller, G., Küllertz, G., Stark, M. J. R., Fischer, G. S., & Lu, K. P. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00083-3 · Cited by 543 · see citing works

A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice.Preprint

Davis, A. C., Wims, M., Spotts, G. D., Hann, S., & Bradley, A. (1993) · Genes & Development · doi:10.1101/gad.7.4.671 · Cited by 531 · see citing works

Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment

Coppola, J. A., & Cole, M. D. (1986) · Nature · doi:10.1038/320760a0 · Cited by 516 · see citing works

The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation

Sontag, E., Fedorov, S. A., Kamibayashi, C., Robbins, D. J., Cobb, M. H., & Mumby, M. C. (1993) · Cell · doi:10.1016/0092-8674(93)90533-v · Cited by 510 · see citing works

c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells

Gregory, M. A., & Hann, S. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.7.2423-2435.2000 · Cited by 469 · see citing works

Ras Enhances Myc Protein Stability

Sears, R. C., Leone, G. W., DeGregori, J. V., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 454 · see citing works

Destruction of Myc by ubiquitin‐mediated proteolysis: cancer‐associated and transforming mutations stabilize Myc

Salghetti, S. E., Kim, S. Y., & Tansey, W. P. (1999) · The EMBO Journal · doi:10.1093/emboj/18.3.717 · Cited by 445 · see citing works

c-Myc regulates mammalian body size by controlling cell number but not cell size

Trumpp, A., Refaeli, Y., Óskarsson, T., Gasser, S., Murphy, M., Martin, G. R., & Bishop, J. M. (2001) · Nature · doi:10.1038/414768a · Cited by 434 · see citing works

Analysis of C-MYC Function in Normal Cells via Conditional Gene-Targeted Mutation

de Alborán, I. M., O’Hagan, R. C., Gärtner, F., Malynn, B. A., Davidson, L., Rickert, R. C., Rajewsky, K., DePinho, R. A., & Alt, F. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00088-7 · Cited by 398 · see citing works

Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene.Preprint

Charron, J., Malynn, B. A., Fisher, P. E., Stewart, V., Jeannotte, L., Goff, S. P., Robertson, E. J., & Alt, F. W. (1992) · Genes & Development · doi:10.1101/gad.6.12a.2248 · Cited by 322 · see citing works

Point mutations in the c–Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas

Bhatia, K., Huppi, K. E., Spangler, G., Siwarski, D. F., Iyer, R., & Magrath, I. T. (1993) · Nature Genetics · doi:10.1038/ng0993-56 · Cited by 285 · see citing works

Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma.

Cifone, M. A., & Fidler, I. J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1039 · Cited by 243 · see citing works

Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo.

Pulverer, B., Fisher, C., Vousden, K. H., Littlewood, T. D., Evan, G. I., & Woodgett, J. R. (1994) · PubMed · Cited by 228 · see citing works

Hierarchical Phosphorylation at N-Terminal Transformation-Sensitive Sites in c-Myc Protein Is Regulated by Mitogens and in Mitosis

Lutterbach, B. A., & Hann, S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.8.5510 · Cited by 220 · see citing works

Mice Lacking Pin1 Develop Normally, but Are Defective in Entering Cell Cycle from G0 Arrest

Fujimori, F., Takahashi, K., Uchida, C., & Uchida, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1736 · Cited by 216 · see citing works

Identification of Positively and Negatively Acting Elements Regulating Expression of the E2F2 Gene in Response to Cell Growth Signals

Sears, R. C., Ohtani, K., & Nevins, J. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5227 · Cited by 212 · see citing works

E2F-1 accumulation bypasses a G1 arrest resulting from the inhibition of G1 cyclin-dependent kinase activity.Preprint

DeGregori, J. V., Leone, G. W., Ohtani, K., Miron, A., & Nevins, J. R. (1995) · Genes & Development · doi:10.1101/gad.9.23.2873 · Cited by 209 · see citing works

Requirement of the Prolyl Isomerase Pin1 for the Replication Checkpoint

Winkler, K. E., Swenson, K. I., Kornbluth, S. A., & Means, A. R. (2000) · Science · doi:10.1126/science.287.5458.1644 · Cited by 172 · see citing works

Pin1 Acts Catalytically to Promote a Conformational Change in Cdc25

Stukenberg, P. T., & Kirschner, M. W. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00245-3 · Cited by 171 · see citing works

Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential.

Henriksson, M., Bakardjiev, A. I., Klein, G., & Lüscher, B. (1993) · PubMed · Cited by 162 · see citing works

The alternatively initiated c-Myc proteins differentially regulate transcription through a noncanonical DNA-binding site.Preprint

Hann, S., Dixit, M., Sears, R. C., & Sealy, L. J. (1994) · Genes & Development · doi:10.1101/gad.8.20.2441 · Cited by 141 · see citing works

Pin1 regulates the timing of mammalian primordial germ cell proliferation

Atchison, F. W., Capel, B., & Means, A. R. (2003) · Development · doi:10.1242/dev.00584 · Cited by 133 · see citing works

The c-Myc Transactivation Domain Is a Direct Modulator of Apoptotic versus Proliferative Signals

Chang, D. W.-W., Claassen, G. F., Hann, S., & Cole, M. D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4309-4319.2000 · Cited by 133 · see citing works

Analysis of Cdc6 function in the assembly of mammalian prereplication complexes

Cook, J. G., Park, C., Burke, T. W., Leone, G. W., DeGregori, J. V., Engel, A., & Nevins, J. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032677499 · Cited by 120 · see citing works

Functional analysis of E2F transcription factor

Nevins, J. R., DeGregori, J. V., Jakoi, L., & Leone, G. W. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)83017-0 · Cited by 86 · see citing works

Sequence curiosity in v-myc oncogene

Papas, T. S., & Lautenberger, J. A. (1985) · Nature · doi:10.1038/318237a0 · Cited by 54 · see citing works

Phosphorylation of RNA Polymerase II CTD Fragments Results in Tight Binding to the WW Domain from the Yeast Prolyl Isomerase Ess1

Myers, J. K., Morris, D. P., Greenleaf, A. L., & Oas, T. G. (2001) · Biochemistry · doi:10.1021/bi0027884 · Cited by 46 · see citing works

AKT/PKB signaling: navigating downstream

Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115 · see citing works

Virus-free induction of pluripotency and subsequent excision of reprogramming factors

Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P., & Woltjen, K. (2009) · Nature · doi:10.1038/nature07864 · Cited by 1,252 · see citing works

Akt signalling in health and disease

Hers, I., Vincent, E. E., & Tavaré, J. M. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.004 · Cited by 1,246 · see citing works

The c-Myc target gene network

Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · see citing works

ERK signalling: A master regulator of cell behaviour, life and fate

Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185 · see citing works

Transcriptional regulation and transformation by Myc proteins

Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,122 · see citing works

FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

Welcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084 · see citing works

The MYC oncogene — the grand orchestrator of cancer growth and immune evasion

Dhanasekaran, R., Deutzmann, A., Mahauad‐Fernandez, W. D., Hansen, A. S., Gouw, A. M., & Felsher, D. W. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00549-2 · Cited by 1,010 · see citing works

The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

Welcker, M., Orian, A., Jin, J., Grim, J. A., Harper, J. W., Eisenman, R. N., & Clurman, B. E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402770101 · Cited by 942 · see citing works

Myc’s broad reach

Eilers, M., & Eisenman, R. N. (2008) · Genes & Development · doi:10.1101/gad.1712408 · Cited by 927 · see citing works

LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism

Cartwright, P., McLean, C. A., Sheppard, A. M., Rivett, D., Jones, K., & Dalton, S. (2005) · Development · doi:10.1242/dev.01670 · Cited by 758 · see citing works

ERK implication in cell cycle regulation

Chambard, J., LeFloch, R., Pouysségur, J., & Lenormand, P. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.010 · Cited by 753 · see citing works

PVT1 dependence in cancer with MYC copy-number increase

Tseng, Y., Moriarity, B. S., Gong, W., Akiyama, R., Tiwari, A., Kawakami, H., Ronning, P., REULAND, B. D., Guenther, K. L., Beadnell, T. C., et al. (2014) · Nature · doi:10.1038/nature13311 · Cited by 724 · see citing works

The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease

Lu, K. P., & Zhou, X. Z. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2261 · Cited by 682 · see citing works

CIP2A inhibits PP2A in human malignancies

Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · see citing works

Prolyl cis-trans isomerization as a molecular timer

Lu, K. P., Finn, G., Lee, T. H., & Nicholson, L. K. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.35 · Cited by 655 · see citing works

Regulation of Raf-1 by direct feedback phosphorylation.

Dougherty, M., Müller, J., Ritt, D. A., Zhou, M., Zhou, X.-Z., Copeland, T., Conrads, T., Veenstra, T., Lu, K., & Morrison, D. (2005) · Molecules and Cells · doi:10.1016/j.molcel.2004.11.055 · Cited by 663 · see citing works

RAF-MEK-ERK pathway in cancer evolution and treatment

Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.010 · Cited by 553 · see citing works

Species- and cell type-specific requirements for cellular transformation

Rangarajan, A., Hong, S. J., Gifford, A., & Weinberg, R. A. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.07.009 · Cited by 555 · see citing works

Mitochondrial Dysfunction in Cancer

Boland, M. L., Chourasia, A. H., & Macleod, K. F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00292 · Cited by 502 · see citing works

The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy

Yuan, J., Dong, X., Yap, J., & Hu, J. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00949-4 · Cited by 500 · see citing works

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

Neviani, P., Santhanam, R., Trotta, R., Notari, M., Blaser, B. W., Liu, S., Mao, H. C., Chang, J. S., Galietta, A., Uttam, A., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.015 · Cited by 477 · see citing works

The ubiquitin-specific protease USP28 is required for MYC stability

Popov, N., Wanzel, M., Madiredjo, M., Zhang, D., Beijersbergen, R. L., Bernards, R., Moll, R., Elledge, S. J., & Eilers, M. (2007) · Nature Cell Biology · doi:10.1038/ncb1601 · Cited by 476 · see citing works

MYC degradation

Farrell, A. S., & Sears, R. C. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014365 · Cited by 468 · see citing works

Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants

Hemann, M. T., Bric, A., Teruya‐Feldstein, J., Herbst, A., Nilsson, J. A., Cordon‐Cardo, C., Cleveland, J. L., Tansey, W. P., & Lowe, S. W. (2005) · Nature · doi:10.1038/nature03845 · Cited by 452 · see citing works

MYC Deregulation in Primary Human Cancers

Kalkat, M., Melo, J. D., Hickman, K. A., Lourenco, C., Redel, C., Resetca, D., Tamachi, A., Tu, W. B., & Penn, L. Z. (2017) · Genes · doi:10.3390/genes8060151 · Cited by 445 · see citing works

PP2A: the expected tumor suppressor

Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426 · see citing works

The Life Cycle of C-Myc: From Synthesis to Degradation

Sears, R. C. (2004) · Cell Cycle · doi:10.4161/cc.3.9.1145 · Cited by 406 · see citing works

The Ubiquitin Ligase HectH9 Regulates Transcriptional Activation by Myc and Is Essential for Tumor Cell Proliferation

Adhikary, S., Marinoni, F., Hock, A., Hulleman, E., Popov, N., Beier, R., Bernard, S., Quarto, M., Capra, M. C., Goettig, S., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.016 · Cited by 403 · see citing works

PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)

Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390 · see citing works

MYC and Breast Cancer

Xu, J., Chen, Y., & Olopade, O. I. (2010) · Genes & Cancer · doi:10.1177/1947601910378691 · Cited by 384 · see citing works

Pin1, a new player in the fate of HIF-1α degradation: an hypothetical mechanism inside vascular damage as Alzheimer’s disease risk factor

Lonati, E., Brambilla, A., Milani, C., Masserini, M., Palestini, P., & Bulbarelli, A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00001 · Cited by 347 · see citing works

Physiological regulation of Akt activity and stability.

Liao, Y., & Hung, M. (2010) · PubMed Central · Cited by 343 · see citing works

Multiple pathways regulated by the tumor suppressor PP2A in transformation

Westermarck, J., & Hahn, W. C. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.02.001 · Cited by 344 · see citing works

Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins

Liou, Y., Zhou, X. Z., & Lu, K. P. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.07.001 · Cited by 326 · see citing works

Target gene-independent functions of MYC oncoproteins

Baluapuri, A., Wolf, E., & Eilers, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0215-2 · Cited by 310 · see citing works

FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression

Ferber, E. C., Peck, B., Delpuech, O., Bell, G. P., East, P., & Schulze, A. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.179 · Cited by 307 · see citing works

KRAS-Mutant non-small cell lung cancer: From biology to therapy

Ferrer, I., Zugazagoitia, J., Herbertz, S., John, W. J., Paz-Ares, L. G., & Schmid‐Bindert, G. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.013 · Cited by 306 · see citing works

Negative regulation of interferon-regulatory factor 3–dependent innate antiviral response by the prolyl isomerase Pin1

Saitoh, T., Tun-Kyi, A., Ryo, A., Yamamoto, M., Finn, G., Fujita, T., Akira, S., Yamamoto, N., Lu, K. P., & Yamaoka, S. (2006) · Nature Immunology · doi:10.1038/ni1347 · Cited by 303 · see citing works

Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma

Brockmann, M., Poon, E., Berry, T., Carstensen, A., Deubzer, H. E., Rycak, L., Jamin, Y., Thway, K., Robinson, S. P., Roels, F., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.005 · Cited by 300 · see citing works

Epigenetic responses to environmental change and their evolutionary implications

Turner, B. M. (2009) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2009.0125 · Cited by 293 · see citing works

The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

Liu, K., Zheng, M., Lu, R., Du, J., Zhao, Q., Li, Z., Li, Y., & Zhang, S. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01304-w · Cited by 289 · see citing works

The alphabet of intrinsic disorder

Theillet, F., Kalmár, L., Tompa, P., Han, K., Selenko, P., Dunker, A. K., Daughdrill, G. W., & Uversky, V. N. (2013) · Intrinsically Disordered Proteins · doi:10.4161/idp.24360 · Cited by 283 · see citing works

The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growthPreprint

Secombe, J., Li, L., Carlos, L. S., & Eisenman, R. N. (2007) · Genes & Development · doi:10.1101/gad.1523007 · Cited by 277 · see citing works

The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target

Zhou, X. Z., & Lu, K. P. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.49 · Cited by 271 · see citing works

Pim kinase-dependent inhibition of c-Myc degradation

Zhang, Y., Wang, Z., Li, X., & Magnuson, N. S. (2008) · Oncogene · doi:10.1038/onc.2008.123 · Cited by 268 · see citing works

PIN1, the cell cycle and cancer

Yeh, E. S., & Means, A. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2107 · Cited by 268 · see citing works

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression

Hayes, T. K., Neel, N. F., Hu, C., Gautam, P., Chénard, M., Long, B. J., Aziz, M., Kassner, M., Bryant, K. L., Pierobon, M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.11.011 · Cited by 266 · see citing works

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis

Saddoughi, S. A., Gencer, S., Peterson, Y. K., Ward, K. E., Mukhopadhyay, A., Oaks, J. J., Bielawski, J., Szulc, Z. M., Thomas, R. J., Selvam, S. P., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201283 · Cited by 265 · see citing works

AMBRA1 links autophagy to cell proliferation and tumorigenesis by promoting c-Myc dephosphorylation and degradation

Cianfanelli, V., Fuoco, C., Lorente, M., Salazar‐Roa, M., Quondamatteo, F., Gherardini, P. F., Zio, D. D., Nazio, F., Antonioli, M., D’Orazio, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3072 · Cited by 258 · see citing works

Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies

Onyango, I. G., Dennis, J., & Khan, S. M. (2016) · Aging and Disease · doi:10.14336/ad.2015.1007 · Cited by 260 · see citing works

The Ins and Outs of MYC Regulation by Posttranslational Mechanisms

Vervoorts, J., Lüscher‐Firzlaff, J., & Lüscher, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600017200 · Cited by 259 · see citing works

Oncogenic PIK3CA-driven mammary tumors frequently recur via PI3K pathway–dependent and PI3K pathway–independent mechanisms

Liu, P., Cheng, H.-L. M., Santiago, S., Raeder, M. B., Zhang, F., Isabella, A. J., Yang, J., Semaan, D. J., Chen, C., Fox, E. A., et al. (2011) · Nature Medicine · doi:10.1038/nm.2402 · Cited by 258 · see citing works

Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production

Funes, J. M., Quintero, M., Henderson, S. R., Martínez, D., Qureshi, U., Westwood, C., Clements, M. O., Bourboulia, D., Pedley, R. B., Moncada, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700690104 · Cited by 256 · see citing works

Protein phosphatase 2A regulatory subunit B56α associates with c-myc and negatively regulates c-myc accumulation

Arnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2832-2844.2006 · Cited by 251 · see citing works

MYC in Oncogenesis and as a Target for Cancer Therapies

Albihn, A., Johnsen, J. I., & Arsenian‐Henriksson, M. (2010) · Advances in cancer research · doi:10.1016/s0065-230x(10)07006-5 · Cited by 240 · see citing works

Phosphorylation-specific prolyl isomerization: is there an underlying theme?

Wulf, G. M., Finn, G., Suizu, F., & Lu, K. P. (2005) · Nature Cell Biology · doi:10.1038/ncb0505-435 · Cited by 238 · see citing works

Involvement of PP2A in viral and cellular transformation

Arroyo, J. D., & Hahn, W. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209038 · Cited by 237 · see citing works

Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy

Στρατικόπουλος, Η., Dendy, M., Szabolcs, M. J., Khaykin, A. J., Lefèbvre, C., Zhou, M., & Parsons, R. E. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.05.006 · Cited by 234 · see citing works

CIP2A Is Associated with Human Breast Cancer Aggressivity

Côme, C., Laine, A., Chanrion, M., Edgren, H., Mattila, E., Liu, X., Jonkers, J., Ivaska, J., Isola, J., Darbon, J.-M., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3283 · Cited by 221 · see citing works

Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia

Gutierrez, A., Pan, L., Groen, R. W. J., Baleydier, F., Kentsis, A., Marineau, J., Grebliunaite, R., Kozakewich, E., Reed, C., Pflumio, F., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci65093 · Cited by 220 · see citing works

Fuzzy complexes: Specific binding without complete folding

Sharma, R., Ráduly, Z., Miskei, M., & Fuxreiter, M. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.07.022 · Cited by 226 · see citing works

Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation

Hydbring, P., Bahram, F., Su, Y., Tronnersjö, S., Högstrand, K., von der Lehr, N., Sharifi, H. R., Lilischkis, R., Hein, N., Wu, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900121106 · Cited by 224 · see citing works

Nuclear ERK: Mechanism of Translocation, Substrates, and Role in Cancer

Maik-Rachline, G., Hacohen-Lev-Ran, A., & Seger, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051194 · Cited by 225 · see citing works

Inhibition of c‐Myc activity by ribosomal protein L11

Dai, M., Arnold, H., Sun, X., Sears, R. C., & Lu, H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601776 · Cited by 207 · see citing works

MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Ahmadi, S. E., Rahimi, S., Zarandi, B., Chegeni, R., & Safa, M. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01111-4 · Cited by 211 · see citing works

Direct interaction between the inhibitor 2 and ceramide via sphingolipid‐protein binding is involved in the regulation of protein phosphatase 2A activity and signaling

Mukhopadhyay, A., Saddoughi, S. A., Song, P., Sultan, I. Y., Ponnusamy, S., Senkal, C. E., Snook, C. F., Arnold, H., Sears, R. C., Hanniui, Y. A., et al. (2008) · The FASEB Journal · doi:10.1096/fj.08-120550 · Cited by 208 · see citing works

c-Myc Phosphorylation Is Required for Cellular Response to Oxidative Stress

Benassi, B., Fanciulli, M., Fiorentino, F., Porrello, A., Chiorino, G., Loda, M. F., Zupi, G., & Biroccio, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.009 · Cited by 207 · see citing works

The Tumor Suppressor PP2A Aβ Regulates the RalA GTPase

Sablina, A. A., Chen, W., Arroyo, J. D., Corral, L. G., Hector-Greene, M., Bulmer, S. E., DeCaprio, J. A., & Hahn, W. C. (2007) · Cell · doi:10.1016/j.cell.2007.03.047 · Cited by 203 · see citing works

Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis

Wulf, G. M., Garg, P., Liou, Y., Iglehart, D. J., & Lu, K. P. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600323 · Cited by 199 · see citing works

Prolyl isomerase Pin1 in cancer

Lu, Z., & Hunter, T. R. (2014) · Cell Research · doi:10.1038/cr.2014.109 · Cited by 203 · see citing works

Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer

Shimamura, T., Chen, Z., Soucheray, M., Carretero, J., Kikuchi, E., Tchaicha, J. H., Gao, Y., Cheng, K. A., Cohoon, T. J., Qi, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3904 · Cited by 203 · see citing works

Myc proteins as therapeutic targets

Gustafson, W. C., & Weiss, W. A. (2010) · Oncogene · doi:10.1038/onc.2009.512 · Cited by 199 · see citing works

Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma

Chesler, L., Schlieve, C. R., Goldenberg, D., Kenney, A. M., Kim, G., McMillan, A., Matthay, K. K., Rowitch, D. H., & Weiss, W. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2769 · Cited by 200 · see citing works

Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation

Deschênes-Simard, X., Gaumont-Leclerc, M.-F., Bourdeau, V., Lessard, F., Moiseeva, O., Forest, V., Igelmann, S., Mallette, F. A., Saba-El-Leil, M. K., Meloche, S., et al. (2013) · Genes & Development · doi:10.1101/gad.203984.112 · Cited by 194 · see citing works

Identification of PP2A Complexes and Pathways Involved in Cell Transformation

Sablina, A. A., Hector, M., Colpaert, N., & Hahn, W. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2855 · Cited by 193 · see citing works

Expression of the AID protein in normal and neoplastic B cells

Pasqualucci, L., Guglielmino, R., Houldsworth, J., Mohr, J., Aoufouchi, S., Polakiewicz, R. D., CHAGANTI, R. S. K., & Dalla‐Favera, R. (2004) · Blood · doi:10.1182/blood-2004-04-1558 · Cited by 193 · see citing works

SCF-mediated protein degradation and cell cycle control

Cambronne, X. A., & Harper, J. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208614 · Cited by 193 · see citing works

Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the V600EBRAF oncogene

Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 186 · see citing works

Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer

Janghorban, M., Farrell, A. S., Allen-Petersen, B. L., Pelz, C., Daniel, C. J., Oddo, J., Langer, E. M., Christensen, D. J., & Sears, R. C. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317630111 · Cited by 186 · see citing works

MYC—Master Regulator of the Cancer Epigenome and Transcriptome

Poole, C. J., & van Riggelen, J. (2017) · Genes · doi:10.3390/genes8050142 · Cited by 177 · see citing works

MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase

Cao, Z., Fan-Minogue, H., Bellovin, D. I., Yevtodiyenko, A., Arzeno, J., Yang, Q., Gambhir, S. S., & Felsher, D. W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3367 · Cited by 179 · see citing works

Myc and Ras oncogenes engage different energy metabolism programs and evoke distinct patterns of oxidative and DNA replication stress

Maya‐Mendoza, A., Ostráková, J., Košař, M., Hall, A., Dušková, P., Mistrík, M., Merchut‐Maya, J. M., Hodný, Z., Bártková, J., Christensen, C., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.001 · Cited by 170 · see citing works

Molecular Consequences of Silencing Mutant K-<i>ras</i> in Pancreatic Cancer Cells: Justification for K-<i>ras</i>–Directed Therapy

Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176 · see citing works

Diverse Functions of Ceramide in Cancer Cell Death and Proliferation

Saddoughi, S. A., & Öğretmen, B. (2013) · Advances in cancer research · doi:10.1016/b978-0-12-394274-6.00002-9 · Cited by 176 · see citing works

β-Catenin-Independent Roles of Wnt/LRP6 Signaling

Acebrón, S. P., & Niehrs, C. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.07.009 · Cited by 172 · see citing works

Oncogenic Signaling Pathways Activated in DMBA-Induced Mouse Mammary Tumors

Currier, N. V., Solomon, S. E., Demicco, E. G., Chang, D. L. F., Farago, M., Ying, H., Dominguez, I. M., Sonenshein, G. E., Cardiff, R. D., Xiao, Z. J., et al. (2005) · Toxicologic Pathology · doi:10.1080/01926230500352226 · Cited by 174 · see citing works

Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function

Hann, S. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.08.004 · Cited by 173 · see citing works

Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary Gland

Wang, X., Cunningham, M., Zhang, X., Tokarz, S. A., Laraway, B. J., Troxell, M. L., & Sears, R. C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1032 · Cited by 165 · see citing works

Oncogenic regulation of tumor metabolic reprogramming

Tarrado‐Castellarnau, M., de Atauri, P., & Cascante, M. (2016) · Oncotarget · doi:10.18632/oncotarget.10911 · Cited by 159 · see citing works

Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation

Rubio, D., García, S., Paz, M. F., de la Cueva, T., López-Fernández, L. A., Lloyd, A. C., Garcı́a-Castro, J., & Bernad, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001398 · Cited by 162 · see citing works

Pim Family Kinases Enhance Tumor Growth of Prostate Cancer Cells

Chen, W. W., Chan, D. C. F., Donald, C. D., Lilly, M. B., & Kraft, A. S. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0007 · Cited by 161 · see citing works

COP 1 conveys warm temperature information to hypocotyl thermomorphogenesis

Park, Y., Lee, H., Ha, J., Kim, J. Y., & Park, C. (2017) · New Phytologist · doi:10.1111/nph.14581 · Cited by 160 · see citing works

The Mevalonate Pathway, a Metabolic Target in Cancer Therapy

Guerra, B., Recio, C., Aranda-Tavío, H., Guerra-Rodríguez, M., García-Castellano, J. M., & Fernández‐Pérez, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626971 · Cited by 160 · see citing works

Sulfopin is a covalent inhibitor of Pin1 that blocks Myc-driven tumors in vivo

Dubiella, C., Pinch, B. J., Koikawa, K., Zaidman, D., Poon, E., Manz, T. D., Nabet, B., He, S., Resnick, E., Rogel, A., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00786-7 · Cited by 161 · see citing works

Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target

Khanna, A., Pimanda, J. E., & Westermarck, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1994 · Cited by 154 · see citing works

Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination

Fang, X., Zhou, W., Wu, Q., Huang, Z., Shi, Y., Yang, K., Chen, C., Xie, Q., Mack, S. C., Wang, X., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151673 · Cited by 153 · see citing works

Mammalian MYC Proteins and Cancer

Tansey, W. P. (2014) · New Journal of Science · doi:10.1155/2014/757534 · Cited by 153 · see citing works

Cellular transformation by Simian Virus 40 and Murine Polyoma Virus T antigens

Cheng, J., DeCaprio, J. A., Fluck, M. M., & Schaffhausen, B. S. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.03.002 · Cited by 152 · see citing works

PINning down the c-Myc oncoprotein

Dominguez-Sola, D., & Dalla‐Favera, R. (2004) · Nature Cell Biology · doi:10.1038/ncb0404-288 · Cited by 30 · see citing works

Abstract IA10: Post-translational regulation of MYC's oncogenic activity

Sears, R. C., Farrell, A., Wang, X., Liang, J. B., Janghorban, M., Su, Y., Allen-Petersen, B. L., Ohlemeyer, M., & Narla, G. (2015) · Molecular Cancer Research · doi:10.1158/1557-3125.myc15-ia10

Abstract A89: Targeting the MYC activation and degradation pathway for the treatment of pancreatic cancer

Farrell, A. S., Allen-Petersen, B. L., Daniel, C. J., Wang, X., Wang, Z., Christensen, D. J., Sheppard, B. C., & Sears, R. C. (2015) · Cancer Research · doi:10.1158/1538-7445.panca2014-a89

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels

Ando, S., Ikeda, S., Tanaka, K., Tomabechi, Y., Yamagata, A., Shirouzu, M., Tsunedomi, R., Nagano, H., Tsuji, S., Sato, K., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2509374123

SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62

Wang, W., Liao, P., Shen, M., Chen, T., Chen, Y., Li, Y. C. A. B. W. H., Lin, X., Ge, X., & Wang, P. (2015) · Oncogene · doi:10.1038/onc.2015.106 · Cited by 37 · see citing works